Pfizer agrees to supply EU with up to 300m doses of coronavirus vaccine
[BENGALURU] Pfizer and German partner BioNTech said on Wednesday they had reached an agreement with the European Commission to supply up to 300 million doses of their experimental coronavirus vaccine.
Deliveries are expected to start by the end of this year, the companies said.
The companies said on Monday their Covid-19 vaccine was more than 90 per cent effective based on initial trial results, and the European Commission had hours later said it would soon sign the contract with the companies.
The companies have a US$1.95 billion contract with the US government to deliver 100 million vaccine doses beginning this year.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue